Lotus Pharmaceutical (1795.TW) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
1.52
2.5
3.48
4.46

Details

Expected EPS
3.8615422788987406
Actual EPS
4.007561212512
Surprise EPS
0.15
Surprise Percent
+3.78%

Description

Lotus Pharmaceutical (1795.TW) has reported earnings of 4.007561212512 per share for Q2 2024.

0 Comments

Share your thoughts